Identification of the novel HLA‐C*03:132:02 allele in a Chinese individual by next‐generation sequencing
HLA · 2024
DOI: 10.1111/tan.15388 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Ziqing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Henan Red Cross Blood Center, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: HLA-C Antigens, Genes, MHC Class I. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Compared with the HLA‐C*03:132:01 allele, HLA‐C*03:132:02 shows one nucleotide substitution at position 270A>C.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Henan Red Cross Blood Center, Zhengzhou, Henan, China.
- Henan Blood Safety Research Institute, Zhengzhou, Henan, China.
ORCID-Profile: Ziqing Wang, Zheng Liu
Zitieren
APA
Wang, Z., Sun, Y., Kang, Y., Li, J., & Liu, Z. (2024). Identification of the novel HLA‐C*03:132:02 allele in a Chinese individual by next‐generation sequencing. HLA. https://doi.org/10.1111/tan.15388
Vancouver
Wang Z, Sun Y, Kang Y, Li J, Liu Z. Identification of the novel HLA‐C*03:132:02 allele in a Chinese individual by next‐generation sequencing. HLA. 2024. doi:10.1111/tan.15388
BibTeX
@article{Wang2024,
author = {Wang, Ziqing and Sun, Yamin and Kang, Yiqing and Li, Jianbin and Liu, Zheng},
title = {Identification of the novel HLA‐C*03:132:02 allele in a Chinese individual by next‐generation sequencing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15388}
}
EUVIMED